todd davis  lifelock inc  zoominfocom healthcare royalty partners  team hc royalty partners about approach team portfolio news contact team team strategic advisory board we are former surgeons pharmaceutical executives bankers equity analysts lawyers and consultants we have decades of investment operational clinical structuring and capital markets experience our strategic advisory board consists of prominent healthcare veterans that enhance the depth and expertise of our team carlos m almodovar principalinvestor relations li s boynton associate gregory b brown md founder thomas k conner chief financial officer warren d cooper mb bs bsc mfpm chief medical officer todd c davis founder samuel d floyd ii associate clarke b futch founder paul j hadden managing director shin w kang phd vice president joshua d kurtz fund controller sean s mansoory associate anthony g rapsomanikis vice president andrew t reardon chief legal officer spencer h schneider ip counsel  chief compliance officer john a urquhart principal amy j vayalattu fund accountant conrad wang md principal christopher a white chief operating officer ting xie phd senior associate clickablefitted our strategic advisory board consists of world renowned healthcare experts with extensive expertise in global manufacturing clinical medicine commercialization of life science products and licensing frank m armstrong md louis p berneman michael g carter md marc d kozin robert s langer scd julie h mchugh natale s ricciardi clickablefitted spotlight gregory b brown md founder gregory b brown md is a cofounder and vice chairman of hcr and the chairman of the strategic advisory board educated as a transplantation immunologist and trained as a thoracic and vascular surgeon dr brown practiced thoracic and vascular surgery in a community setting where he also founded and led an hmo he brings particular expertise in the scientific technical clinical and medical evaluation of products as well as in healthcare systems and payor  reimbursement dynamics he has been involved in sourcing diligencing and closing more than  billion of royalty financings before cofounding hcr dr brown was a partner at paul capital partners where he comanaged that firms royalty investments as a member of the royalty management committee prior to beginning his principal investment career in  dr brown was cohead of investment banking and head of healthcare at adams harkness  hill now canaccord genuity and a ranked biotechnology research analyst at vector securities international dr brown holds a ba from yale an md from suny upstate medical center and an mba from harvard business school he currently serves on the board of monosol rx and is a board observer at vanderbilt sarl li s boynton associate li s boynton joined hcr as an associate in  previously she worked in equity research covering the large cap pharma and largesmid cap biotechnology sectors at guggenheim ms boynton holds a bs in molecular biology from yale university todd c davis founder todd c davis is a cofounder managing partner and chairman of the portfolio management committee at hcr he has particular expertise in the commercial operational and licensing aspects of the healthcare industry and is responsible for the management of hcrs existing portfolio of over  billion mr davis has been involved in over  billion in healthcare principal investments including sourcing conducting due diligence and closing more than  billion in royalty financings in addition mr davis has run hcrs business development activities coordinated the firms public relations activities and served on the investment committee previously mr davis was a partner at paul capital partners where he comanaged that firms royalty investments as a member of the royalty management committee he also served as a partner responsible for biopharmaceutical growth equity investments at apax partners prior to beginning his principal investment career in  mr davis held sales and marketing roles at abbott laboratories and worked in business development licensing and general management at elan pharmaceuticals mr davis holds a bs from the us naval academy and an mba from harvard business school he currently serves on the boards of suneva medical ligand pharmaceuticals acufocus and tearscience clarke b futch founder clarke b futch is a cofounder managing partner and chairman of the investment committee at hcr he has been raising and deploying capital in the healthcare royalty market for more than a dozen years since  he has led more than  royalty investments representing nearly  billion of invested capital over the course of his career mr futch has raised over  billion across five investment funds and executed more than  transactions including royalty equity debt and ma deals at hcr partners he also leads the firms fundraising activities before cofounding hcr mr futch served as a partner at paul capital partners where he comanaged the firms royalty investments as a member of the royalty management committee he previously served as a founder of the healthcare group at thomas weisel partners and as a vice president at raymond james mr futch was previously named one of the future leaders in biotech finance by bioworld one of the industrys leading publications he holds a ba magna cum laude from vanderbilt university and a jd from the university of virginia school of law mr futch also serves on the board of suneva medical paul j hadden managing director paul j hadden is a managing director and member of the investment committee at hcr he joined the firm in  and is focused primarily on hcrs activities in the united kingdom and europe including deal sourcing and structuring mr hadden has previously led the firms efforts with universities and inventors as well as its global business development activities mr hadden has over a decade of experience investing in and advising biotechnology and pharmaceutical companies and to date has been involved in sourcing conducting due diligence andor closing over  million in royalty transactions prior to hcr mr hadden served as a principal at the frankel group llc a boutique management consulting firm serving the life sciences industry where he advised leading pharmaceutical biotechnology and generic clients mr hadden started his career at new yorkpresbyterian hospital as a senior financial analyst providing financial planning support to the program development and clinical services division mr hadden holds a ba from yale college and an mph from the yale school of public health conrad wang md principal conrad wang md joined hcr as a principal in  trained as an orthopedic surgeon dr wang has over a decade of experience investing and structuring acquisitions in healthcare dr wang most recently was senior director corporate development at medtronic plc where he led crossfunctional deal teams in evaluating and executing acquisitions strategic alliances joint ventures and minority investments prior to medtronic dr wang was a principal investor at three arch partners a healthcare venture capital firm where he sourced invested in and was a board member for medical device healthcare services and therapeutics companies dr wang holds a bs from massachusetts institute of technology mit an md from the harvardmit division of health sciences and technology at harvard medical school and an mba from harvard business school where he was named a baker scholar he completed his postgraduate training in the harvard combined orthopedic residency program he currently serves as a board observer for acufocus and tearscience cici zheng associate cici zheng is an associate of hcr prior to joining hc royalty she was an analyst in the healthcare investment banking division at ubs investment bank where she focused on mergers and acquisitions as well as debt and equity financings across the healthcare industry ms zheng holds a ba from the university of pennsylvania emilie c mckenna associate emilie mckenna is an associate of hcr prior to joining hcr she was an analyst in the healthcare investment banking group at cowen and company where she focused on mergers and acquisitions as well as debt and equity financings ms mckenna holds a ba from bowdoin college sean s mansoory associate sean s mansoory joined hcr as an associate in  previously he worked in the healthcare investment banking groups at bmo capital markets and janney capital markets prior to janney he worked as a market research analyst at boston biomedical consultants now quintilesims a boutique consulting firm primarily focused on the in vitro diagnostics ivd sector sean holds a bs in biochemistry and premedicine from trinity college ct shin w kang phd vice president shin w kang phd joined hcr as a vice president in  dr kang focuses on hcrs research efforts as well as business development related to us based universities and inventors he most recently served as a vice president of equity research at wells fargo securities covering the biotechnology sector prior to wells fargo dr kang managed technology intellectual property and business development at the mount sinai school of medicine he holds a phd in biological chemistryimmunology from the university of california los angeles an mba from columbia business school and a bs from the university of california davis dr kang also conducted research at genentech as a postdoctoral fellow john a urquhart principal john a urquhart is a principal at hcr mr urquhart joined hcr in  and since then he has served various roles of increasing responsibility he has over a decade of healthcare investing experience in the royalty and structured finance market mr urquhart is based in boston and is responsible for the firms business development efforts in the greater boston region prior to hcr mr urquhart was an investment banking analyst at cowen and company where he focused on mergers and acquisitions as well as debt and equity financings mr urquhart holds a ba from brown university and a mba from the wharton school of the university of pennsylvania anthony g rapsomanikis director of west coast business development anthony g rapsomanikis is vice president and director of west coast business development at hcr prior to joining the firm in  as an associate he worked as an analyst in the healthcare investment banking group at stifel nicolaus weisel and its predecessor firm thomas weisel partners where he was focused on mergers and acquisitions debt and equity financings prior to stifel mr rapsomanikis was an analyst at silverwood partners where he advised middle market companies on private capital raises and ma transactions mr rapsomanikis holds a bba cum laude from the university of massachusetts amherst pei zhou cfa associate pei zhou cfa joined hcr as an associate in  previously he worked as an investment banking analyst at mts health partners a boutique healthcare merchant bank prior to mts he worked in corporate finance at comcastnbcuniversal pei holds a ba in economics from the university of pennsylvania ting xie phd senior associate ting xie phd joined hcr as an associate in  previously he was a member of ab bernsteins ii ranked equity research team covering biotech and specialty pharma sectors dr xie holds a phd from harvard university where he focused on cuttingedge small molecule drug development and related clinical studies at harvard medical school and danafarber cancer institute prior to that he received his bsc in chemistry and biology from tsinghua university thomas k conner chief financial officer thomas k conner is the chief financial officer and a managing director at hcr prior to joining hcr mr conner was the coo of investment banking at cowen  company mr conner spent more than twenty years with cowen  company and was its chief financial officer until its merger with ramius prior to joining cowen mr conner worked for tlp leasing programs where he managed the accounting operations of  public and private limited partnerships previously mr conner worked for atlantic capital corporation he began his career at deloitte haskins  sells in  mr conner holds a bba from the university of massachusetts amherst and is a certified public accountant licensed in the state of new york andrew t reardon chief legal officer andrew t reardon is the chief legal officer at hcr prior to joining hcr mr reardon was a senior associate at willkie farr  gallagher mr reardons experience includes advising private equity funds hedge funds lenders and operating companies on matters including fund formations financings equity issuances mergers and acquisitions leveraged buyouts royalty transactions restructurings and corporate governance mr reardon received a jd with high distinction from the university of iowa college of law where he was the recipient of the alan i widiss faculty scholar award and a ba with honors from the state university of new york college at old westbury mr reardon is a former officer with the united states army national guard spencer h schneider ip counsel  chief compliance officer spencer h schneider is the chief compliance officer and intellectual property counsel at hcr mr schneider helped establish hcrs compliance program handled all aspects of the firms registration as an investment advisor with the sec and manages all compliance functions  he is a registered patent attorney with extensive experience in conducting intellectual property due diligence for corporate transactions prior to joining hcr mr schneider was a principal at speyside capital advisors a boutique advisory firm helping to facilitate commercialization of university inventions previously mr schneider was an associate in the intellectual property groups of dewey  leboeuf ropes  gray and cooper  dunham he has conducted patent due diligence for multiple types of transactions including public offerings venture capital financings mergers and acquisitions leveraged buyouts and royalty transactions mr schneider holds a ba in biology from columbia college a ms in biochemistry and molecular biology from new york medical college and a jd from cardozo school of law frank m armstrong md frank m armstrong md is a member of hcrs strategic advisory board over the course of his tenured career dr armstrong has served as chief executive officer at a number of healthcare and biopharmaceutical companies including fulcrum pharma plc curagen corporation bioaccelerate holdings inc provensis ltd and phoqus pharmaceuticals plc dr armstrong has also worked in big pharma as head of worldwide product development at bayer ag a senior vice president at zeneca pharmaceuticals now astrazeneca plc and a senior vice president at merck serono dr armstrong holds an mbchb from the university of edinburgh and became a member of the royal college of physicians in  he was elected a fellow of the royal college of physicians edinburgh in  and was elected a fellow of the faculty of pharmaceutical physicians in  michael g carter md michael g carter md is a member of hcrs strategic advisory board and investment committee dr carter is a venture partner at sv life sciences advisers llp and serves as a nonexecutive director of micromet inc fulcrum pharma plc santarus inc and gtx inc previously dr carter was a member of the strategic advisory board for the paul royalty funds from  to  dr carter held numerous positions with zeneca pharmaceuticals now astrazeneca plc including international marketing director international medical director and serving on that companys board dr carter also held numerous positions with roche products ltd from  to  including director of the pharmaceutical division head of medical development and medical affairs and an adverse reactions physician for nearly a decade he served on the uk governments medicines commission and prior to entering the pharmaceutical industry was a practicing physician dr carter holds a diploma in pharmaceutical medicine an mbchb from sheffield university medical school a bpharm from london universitys school of pharmacy and is a member of the pharmaceutical society he was elected a fellow of the royal pharmaceutical society a fellow of faculty of pharmaceutical medicine of the royal college of physicians and a fellow of the royal college of physicians edinburgh nicholas l teti jr nicholas l teti jr is a member of hcrs strategic advisory board he is chairman of the board and ceo of suneva medical prior to suneva medical mr teti was chairman of the board of isolagen inc and until january  was also the companys chief executive officer previously mr teti served as chairman president and chief executive officer of the inamed corporation from  through the allergan acquisition prior to inamed mr teti spent twentyfive years at dupont and dupont merck where he held a number of senior management positions including president and ceo of dupont pharmaceuticals he currently serves on the board of enteromedics mr teti holds a ba and an mba from st josephs university louis p berneman lead advisor nonprofit institutions louis p berneman serves as the lead advisor nonprofit institutions for hcr mr berneman is a past president of the association of university technology managers autm a global network of more than  universities and other nonprofit research institutions focused on licensing technology created through academic and nonprofit research he is also a former vice president and trustee of the licensing executives society les a professional licensing and technology transfer society comprised of over  members mr berneman served on the strategic advisory board for the paul royalty funds for nine years and was managing director of the center for technology transfer at the university of pennsylvania currently mr berneman heads texelerate llc a technology transfer consultancy focusing on assisting institutions investors entrepreneurs and companies with licensing transactions royalty monetizations and creating financing for startups he is also a founding partner of osage university partners mr berneman holds a ba from the pennsylvania state university a teaching credential from university of california at santa barbara and an ma mt and ed d from teachers college columbia university he is also a certified licensing professional joshua d kurtz fund controller joshua d kurtz is a fund controller at hcrp prior to joining hcr mr kurtz was a fund accounting manager at chilton investment company where he was a team leader within the group and managed all aspects of the fund accounting functions before joining chilton mr kurtz worked at cowen investment management formerly ramius where he served as a vice president in the accounting group responsible for accounting and financial reporting for multiple investment funds prior to ramius mr kurtz was a senior accountant in the audit assurance services investment management division of deloitte and touche where he specialized in the audits of private equity and hedge funds mr kurtz holds a bba from baruch college and is a certified public accountant licensed in the state of new york carlos m almodovar principal  investor relations carlos m almodovar is a principal in the investor relations group at hcr prior to joining hcr mr almodovar was director business development at strategic value partners an alternative investment firm focused on distressed debt prior to joining strategic value partners mr almodovar served as an associate director for ubs investment bank where he focused on raising capital for external private equity managers before ubs investment bank mr almodovar served as an analyst in real estate for lehman brothers mr almodovar holds a bs from cornell university robert s langer scd robert s langer scd is a member of hcrs strategic advisory board he is a david h koch institute professor and founder of the langer lab at the massachusetts institute of technology dr langer previously served as a member of the united states food and drug administrations science board the fdas highest advisory board from    and as its chairman from  he has helped start  companies and more than  pharmaceutical chemical biotechnology and medical device companies have licensed or sublicensed langer lab patents over the course of his tenured career dr langer has received over  major awards including the  wolf prize in chemistry which is considered the isreali nobel prize the  united states national medal of science the  united states national medal of technology and innovation and the charles stark draper prize the equivalent of the nobel prize for engineers he has also been elected to the institute of medicine of the national academy of sciences the national academy of engineering and the national academy of sciences dr langer has received  honorary doctorates including honorary degrees from both harvard and yale he received his bachelors degree from cornell university and his scd from massachusetts institute of technology both in chemical engineering julie h mchugh julie h mchugh is a member of hcrs strategic advisory board ms mchugh most recently served as chief operating officer for endo health solutions inc from march  through may  where she was responsible for the specialty pharmaceutical and generic drug businesses prior to joining endo ms mchugh was the chief executive officer of nora therapeutics inc a venture capital backed biotech startup company focused on developing novel therapies for the treatment of infertility disorders before that she served as company group chairman for johnson  johnsons jj worldwide virology business unit and previously she was president of centocor inc a jj subsidiary while at jj ms mchugh oversaw the development and launches of several products including remicade® infliximab prezista® darunavir and intelence® etravirine and she was responsible for oversight of a research and development portfolio including compounds for hiv hepatitis c and tuberculosis prior to joining centocor ms mchugh led the marketing communications for gastrointestinal drug prilosec® omeprazole at astramerck inc she currently serves on the board of visitors for the smeal college of business of the pennsylvania state university as well as on the board of directors of ironwood pharmaceuticals inc aerie pharmaceuticals inc epirus biopharmaceuticals inc and trevena inc all publicly held companies and the new xellia group a privately held company she previously served on the board of directors for viropharma inc the biotechnology industry organization bio the pennsylvania biotechnology association and the new england healthcare institute nehi ms mchugh received her mba from st josephs university and her bs from pennsylvania state university marc d kozin marc d kozin is a member of hcrs strategic advisory board he is a senior advisor and former president of lek consulting a global management consulting firm that helps clients solve their most critical business problems mr kozin has  years of experience in strategy consulting and ma management both domestically and internationally he also has deep industry expertise advising biopharmaceutical life sciences and medtech companies during his tenure at lek mr kozin advised senior executives in life sciences and other industries to help them identify new growth opportunities build value pursue highlyprofitable mergers and acquisitions and support sustained growth he helped open the firms boston office in  and oversaw the growth of the firms us operations including the companys acquisition of shareholder value consulting firm alcar in  in  consulting magazine named mr kozin one of the  most influential consultants in recognition of his leadership and results for clients he holds a ba magna cum laude in economics from duke university and an mba with distinction from the wharton school at the university of pennsylvania mr kozin currently sits on the boards of endocyte inc dyax corporation helomics™ corporation medical simulation corporation ufp technologies and crunchtime information systems neil j campbell neil j campbell joined hcr as an advisor in  he currently serves as president  ceo of helomics™ corporation chairman of mosaigen® corporation and as a senior research fellow at the university of liverpool over the course of his career mr campbell has successfully developed andor introduced more than  products and services in the areas of pharmaceuticals medical devices clinical  industrial diagnostics consumer healthcare products medical software research products bioinformatics nanotechnology highperformance computing and internetofthings he has held clevel positions at child health research institute supernova diagnostics inc endeavour capital entremed pharmaceuticals nasdaq enmd and celera genomics nasdaqcra mr campbell has also served in general and executive management positions at life technologies inc nasdaq life igen inc acquired by roche nasdaqigen and abbott laboratories nyse abt mr campbell serves on several industry government nonprofit and company boards and is an active author on a wide variety of subjects relating to the research development and commercialization of science and technology he is pursuing a doctorate from the university of liverpool and holds an mba and ma from webster university and a bsba from norwich university warren d cooper mb bs bsc mfpm warren d cooper mb bs bsc mfpm is the chief medical officer and a managing director at hcr partners dr cooper previously served as an industry advisor to hcr partners he is a uktrained physician with over  years of experience in the global pharmaceutical industry dr cooper was the founding ceo of prism pharmaceuticals a venturebacked specialty pharmaceutical company that he led from inception to the sale of the company to baxter international in may  with a background in cardiology and cardiac surgery he spent  years with merck initially as a uk clinical research physician then as head of european and subsequently worldwide clinical research operations for merck research laboratories across all therapeutic areas moving to astramerck now astrazeneca plc he led that companys cardiovascular business division a role with full business lifecycle leadership from inlicensing through development to pl responsibility for sales and marketing dr cooper currently serves as the lead director on the board of zynerba pharmaceuticals and is a member of the faculty of pharmaceutical medicine of the royal colleges of physicians of the united kingdom and of the international society of hypertension natale s ricciardi natale s ricciardi is a member of hcrs strategic advisory board he spent his entire year biopharmaceutical career at pfizer inc prior to his retirement in  mr ricciardi served as president pfizer global manufacturing senior vice president pfizer inc and as a member of the pfizer executive leadership team in addition to his corporate leadership role mr ricciardi was directly responsible for all of pfizers internal and external supply organization – a global enterprise with as many as  employees and more than  manufacturing facilities supplying small and large molecule pharmaceuticals vaccines consumer nutrition and animal health products by working with research from product codevelopment regulatory approvals manufacturing and launch his first decade at pfizer was spent performing technical and supervisory roles in the new york area mr ricciardi then relocated to puerto rico where he led pfizers growing manufacturing operations and ultimately included sales and marketing in the caribbean he returned to the mainland in  as vice president of manufacturing for pfizers animal health group in  he was given responsibility for pfizers us manufacturing operations and assumed global responsibilities in  mr ricciardi holds a bs in chemical engineering from the city college of new york and an mba in finance and international business from fordham university  he currently serves on the board of directors of dynavax technologies amy j vayalattu fund accountant amy j vayalattu joined hcr as a fund accountant in  she previously served as an assurance associate in the financial services group at mcgladrey llp in this role she was responsible for conducting risk analysis and audits for private equity funds fundoffunds and hedge funds she previously served in the federal tax department at ibm amy holds a ba in public accounting from pace university christopher a white chief operating officer christopher a white joined hcr as chief operating officer in  and became a member of the investment committee in  he has over twenty years of legal financial and operational experience he previously served as managing director and head of investment banking at janney montgomery scott llc where he was responsible for leading the strategic direction business development and corporate finance activities of the investment banking division within the capital markets group prior to joining janney in  mr white spent over a decade at cowen group inc where he held a number of senior management positions including chief administrative officer chief financial officer and chief operating officer he previously served in senior leadership positions at salomon smith barney and spent seven years as a securities and mergers and acquisitions lawyer mr white holds a ba from amherst college and a jd from the university of michigan law school samuel d floyd ii associate samuel d floyd ii joined hcr as an associate in  previously he worked in the financial sponsors group of the jp morgan private bank where he advised senior private equity professionals regarding their investing banking credit and estate planning needs mr floyd holds a bs magna cum laude from the sybil c mobley school of business at florida am university copyright   healthcare royalty partners  disclaimer follow us   todd c davis executive profile  biography  bloomberg july    am et capital markets company overview of healthcare royalty partners snapshotpeople  overviewboard memberscommittees executive profile todd c davis cofounder and managing partner healthcare royalty partnersagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr todd c davis serves as managing director at suneva medical inc mr davis serves as a managing director at cowen group inc mr davis is a cofounder since january  and managing partner at healthcare royalty partners mr davis was a founding managing director at healthcare royalty partners in and spearheads its global business development efforts and coordinates its public relations activities mr davis was a partner at paul capital partners where he comanaged  that firms royalty investments he was responsible for sourcing and evaluating royalty and revenueinterest investment opportunities in the united states mr davis focused primarily on united states biopharmaceutical investments and led investment efforts in public companies and private companies as well as equity debt and royalty structures within that arena he has led structured and closed over  additional intellectual property licenses as well as growth equity and debt deals he has played a pivotal role in sourcing evaluating and negotiating united states life science investment opportunities he was a partner of healthcare team at apax partners llp since  where mr davis was responsible for sourcing evaluating and negotiating pharmaceutical life science biopharmaceutical growth equity investments he joined apax partners healthcare team in  he pursued investments in pharmaceuticals and specialty pharmaceuticals mr davis served as the vice president of global licensing and business development at elan drug delivery in this role he was responsible for all business aspects of elan’s drug delivery technologies including clinical marketing licensing and product development prior to beginning his principal investment career in  mr davis was at abbott laboratories as a product manager for diagnostic automation systems and worked in field of sales and was also in the launch team for several breakthrough diagnostic products he is chairman of suneva medical inc since august   he served as vice chairman of suneva medical inc until august   he is a board observer at tearscience he serves as chairman of the board of helomics corporation and serves as director since november  he serves on the board of acufocus mr davis has been an independent director at ligand pharmaceuticals incorporated since march   shore therapeutics nuron biotech and suneva medical inc he served as chairman at suneva medical inc he served as a director of sheffield pharmaceuticals verus pharmaceuticals prism pharmaceuticals prometheus laboratories sensys medical inc and skinmedica inc mr davis served for several years as an officer in the united states navy initially as a naval aviator and subsequently in the surface fleet he has expertise in the commercial operational and licensing aspects of potential investments mr davis has more than  years of experience in marketing operational management and technology licensing he has a global reach and deep experience in commercializing healthcare technologies mr davis has earned an mba from the harvard business school and a bs from the united states naval academy at annapolisread full background corporate headquarters  atlantic streetstamford connecticut united statesphone fax  board members memberships chairmansuneva medical incpresentindependent directorligand pharmaceuticals incorporatedpresentchairman of the boardhelomics corporation education mba harvard business schoolbs united states naval academy other affiliations apax partners llpsensys medical incligand pharmaceuticals incorporatedhelomics corporationprometheus laboratories incpaul capitalabbott laboratorieselan corporation limitedsheffield pharmaceuticals incharvard business schoolskinmedica incpaul royalty fund ii lpunited states naval academyartes medical incprism pharmaceuticals incverus pharmaceuticals inccowen group incpaul royalty fund iii lphealthcare royalty partners lpsuneva medical inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact healthcare royalty partners please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close meet the team  buckhead cosmetic dentist  dr todd davis home cosmetic dentistry porcelain veneers dental bonding teeth whitening tmj treatment tmj symptoms tmj therapy restorative dentistry dental implants dental crowns inlaysonlays fullmouth restoration dentures general dentistry exams and screenings teeth cleaning white fillings extractions periodontal therapy sleep apnea oral sedation meet the team dr todd davis thelma allen getta gavrila diana rasa about us office tour mapdirections financing options  west wieuca road atlanta georgia  new patients  current patients   request an appointment name address phone email meet the team at the buckhead dental practice of todd davis dds    at our practice we take your care very personally we value each and every one of our patients and take the time to get to know each individual we’re not here to just fill a cavity and send you on your way we’re here to help you enjoy the best dental health possible we build relationships with our patients and we’ll be here for you when you need us  oral sedation meet dr todd davis     west wieuca road atlanta ga  new patients  current patients  email todddavisddsbellsouthnet todd c davis dds accessibility log in lgnd todd c davis insider trades for ligand pharmaceuticals inc bulletin us employment costs up  in second quarter » us economicgrowth rate picks up secondquarter gdp  » investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ligand pharmaceuticals inc nasdaq lgnd go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ligand pharmaceuticals inc after hours  quotes are delayed by  min jul    pm lgnd quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual todd c davis mr todd c davis is independent director at ligand pharmaceuticals inc founder at healthcare royalty management llc and chairman at helomics corp he is on the board of directors at ligand pharmaceuticals inc and suneva medical inc mr davis was previously employed as a managing director by cowen group inc partner by paul capital partners lp and by apax partners inc a product manager by abbott laboratories and a vice president by elan pharmaceuticals inc he also served on the board at artes medical inc and verus pharmaceuticals inc mr davis is a former us naval officer and holds a bs from the us naval academy and an mba in business from the harvard university graduate school of business transactions date shares transaction value     award at  per share      gift at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      award at  per share      award at  per share      gift at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      award at  per share      award at  per share      award at  per share      award at  per share      disposition at  per share      disposition at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr john l higgins chief executive officer  director mr matthew w foehr president  chief operating officer mr matthew e korenberg cfo principal accounting officer  vpfinance dr vincent antle vptechnical operations  quality assurance dr james d pipkin vice presidentnew product development mr glenn dourado senior directorbusiness development mr todd pettingill investor relations contact ms audrey warfieldgraham vice presidenthuman resources mr charles s berkman secretary vice president  general counsel dr john w kozarich chairman mr todd c davis independent director mr jason m aryeh independent director dr john l lamattina independent director mr sunil patel independent director dr stephen l sabba independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest achevron swings to profit as charges shrink aus gdp speeds up to  in nd quarter achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  aaugust gold rises  at oz atreasury yields tick lower after secondquarter gdp data abreakinggold climbs after first read of secondquarter gdp ahpe ceo meg whitman says she won’t be uber’s next ceo aus dollar holds weakness following gdp data loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft todd c davis  new philadelphia oh  company information products resources my account talk to a db advisor  business directory oh new philadelphia business services nec business services at noncommercial site todd c davis t todd c davis claim this business  boltz rd se new philadelphia oh  get directions business info founded  incorporated annual revenue  employee count  industries business services at noncommercial site contacts todd davis contact business your email address subject message send message company summary todd c davis was founded in  and is located at  boltz rd se in new philadelphia it employs  employees and is generating approximately  in annual revenue verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   t view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved todd c davis  riverside ca  company information products resources my account talk to a db advisor  business directory ca riverside nonclassifiable establishments nonclassifiable establishments todd c davis t todd c davis claim this business  limonite ave riverside ca  get directions business info founded  incorporated annual revenue  employee count  industries nonclassifiable establishments contacts  contact business your email address subject message send message company summary since  the company has been providing nonclassifiable establishments verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   t view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved todd c davis  suneva medical infosunevamedicalcom  facebooklinkedinyoutube   suneva medical exceptional aesthetics results and enduring patient satisfaction exceptional aesthetics results and enduring patient satisfaction todd c davisyou are herehometeammatetodd c davis todd davis is a founding managing director at healthcare royalty partners mr davis has been involved in over  billion in healthcare principal investments including sourcing conducting due diligence and closing more than  billion in royalty financings mr davis has led structured and closed over  additional intellectual property licenses as well as growth equity and debt deals before cofounding healthcare royalty partners mr davis was a partner at paul capital partners where he comanaged royalty investments as a member of the royalty management committee mr davis also served as a partner responsible for biopharmaceutical growth equity investments at apax partners prior to beginning his principal investment career in  mr davis held various sales and product management roles at abbott laboratories and worked in business development operations and licensing at elan pharmaceuticals mr davis has a bs from the us naval academy and an mba from harvard university mr davis currently serves on the boards of helomics corporation ligand and suneva medical news suneva medical celebrates  years of steady growth with flagship brand bellafill aesthetics industry veteran pat altavilla joins suneva medical as vice president of marketing suneva appoints preston romm to chief executive officer and fortifies board of directors with industry leaders preston romm joins suneva medical as chief operating officer suneva medical closes  million financing to support continued growth opportunities suneva medical recognizes june acne awareness month and reveals results of new acne scar survey suneva medical announces landmark clinical study confirming longterm safety and effectiveness of bellafill® through five years fda team archive  suneva medical infosunevamedicalcom  facebooklinkedinyoutube   suneva medical exceptional aesthetics results and enduring patient satisfaction exceptional aesthetics results and enduring patient satisfaction archivesyou are herehometeammate